Search

everythinglearnresearchcommunity

for

Search:↓

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Tph cells are linked to the severity of systemic lupus erythematosus.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Belatacept may be a promising treatment for alopecia areata.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.